Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Skin cancer, Kaposi sarcoma
Trial Status:  Active
Results 1-21 of 21 for your search:
Start Over
Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ACTG A5264, 1U01AI068636, NCT01352117
Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ACTG A5263, 1U01AI068636, U01CA121947, NCT01435018
Pomalidomide for Kaposi Sarcoma in People With or Without HIV
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120047, 12-C-0047, NCT01495598
A Study of Selumetinib in Patients With Kaposi's Sarcoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: STH16059, 2011-003099-35, NCT01752569
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 090130, 09-C-0130, NCT00923936
A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: STH15195, 2008-006007-23, NCT01140737
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: C41-10, NCT01296815
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALDOXORUBICIN-P2-KS-01, NCT02029430
Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-089, NCI-2014-00638, U01CA121947, NCT02137564
Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18 to 80
Sponsor: Other
Protocol IDs: P130944, 2014-001741-24, NCT02212639
Clinical Usefulness of Optical Skin Biopsy
Phase: Phase I
Type: Diagnostic, Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 9361700212, NTUH-94M29, NCT00154921
Nivolumab and Ipilimumab in Treating Patients With Advanced HIV Associated Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2015-00461, AMC-095, U01CA121947, NCT02408861
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-058, U01CA121947, CDR0000590397, NCT00695422
124I-FIAU Imaging in EBV and KSHV Associated Cancers
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: J09111, NA_00032681, P01CA015396, NCT00982449
Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 010038, 01-C-0038, NCT00006518
Development of Serologic Assays for Human Herpes Virus-8
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: Not specified
Sponsor: NIAID
Protocol IDs: 999907018, 07-CC-N018, NCT00395278
History of the KSHV Inflammatory Cytokine Syndrome (KICS)
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110220, 11-C-0220, NCT01419561
Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: not specified
Sponsor: NCI
Protocol IDs: 999906194, 06-C-N194, NCT00904579
Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe
Phase: No phase specified
Type: Health services research, Natural history/Epidemiology
Status: Active
Age: 1 to 80
Sponsor: Other
Protocol IDs: 12-0816, NCT01764360
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J13174, NA_00092477, NCT02080416
Evaluation and Treatment of Patients With Dermatologic Diseases
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: 960102, 96-C-0102, NCT00001506
Start Over